Subfoveal choroidal neovascularization in uveitis.
Only rarely can the development of subretinal foveal or parafoveal neovascularization be observed in patients with chronic uveitis. We report herein the clinical characteristics pertaining to neovascular membranes and the treatment thereof in 3 patients afflicted with either sarcoidosis (2 patients) or Behçet syndrome (1 patient). Peroral steroids contributed to a reduction of neovascular membranes in 1 patient with sarcoidosis. The management of uveitis is mandatory for the prevention of subretinal foveal neovascular membranes.
Inagaki
M
M
Department of Ophthalmology, Fujita Health University, Toyoake, Japan.
Harada
T
T
Kiribuchi
T
T
Ohashi
T
T
Majima
J
J
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D002829:Choroid / Q000098:blood supply* / Q000473:pathology; D002908:Chronic Disease; D005260:Female; D005451:Fluorescein Angiography; D005584:Fovea Centralis; D005654:Fundus Oculi; D006801:Humans; D008875:Middle Aged; D009389:Neovascularization, Pathologic / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D011239:Prednisolone / Q000627:therapeutic use; D012507:Sarcoidosis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D014792:Visual Acuity
D000893:Anti-Inflammatory Agents; D011239:Prednisolone